Business Description
Applied Therapeutics Inc
NAICS : 325412
SIC : 2834
Compare
Compare
Traded in other countries / regions
2UV.GermanyAPLT.USA IPO Date
2019-05-13Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.52 | |||||
| Equity-to-Asset | -0.14 | |||||
| Debt-to-Equity | -0.32 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -22.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15 | |||||
| 3-Year EPS without NRI Growth Rate | 15 | |||||
| 3-Year FCF Growth Rate | 10 | |||||
| 3-Year Book Growth Rate | -63.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.41 | |||||
| 9-Day RSI | 57.19 | |||||
| 14-Day RSI | 55.42 | |||||
| 6-1 Month Momentum % | 75.46 | |||||
| 12-1 Month Momentum % | 28.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.87 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -663.29 | |||||
| Net Margin % | -652.2 | |||||
| ROE % | -449.19 | |||||
| ROA % | -129.62 | |||||
| ROIC % | -359.82 | |||||
| ROC (Joel Greenblatt) % | -6059.91 | |||||
| ROCE % | -436.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.78 | |||||
| EV-to-EBIT | -0.89 | |||||
| EV-to-Forward-EBIT | -0.85 | |||||
| EV-to-EBITDA | -0.89 | |||||
| EV-to-Forward-EBITDA | -0.85 | |||||
| EV-to-Revenue | 5.9 | |||||
| EV-to-FCF | -1.04 | |||||
| Earnings Yield (Greenblatt) % | -112.36 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:APLT
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Applied Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.66 | ||
| EPS (TTM) ($) | -1.7 | ||
| Beta | 2.22 | ||
| Volatility % | 151.94 | ||
| 14-Day RSI | 55.42 | ||
| 14-Day ATR ($) | 0.146831 | ||
| 20-Day SMA ($) | 1.4705 | ||
| 12-1 Month Momentum % | 28.46 | ||
| 52-Week Range ($) | 0.4995 - 2.18 | ||
| Shares Outstanding (Mil) | 57.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Applied Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Applied Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Applied Therapeutics Inc Frequently Asked Questions
What is Applied Therapeutics Inc(APLT)'s stock price today?
The current price of APLT is $1.47. The 52 week high of APLT is $2.18 and 52 week low is $0.50.
When is next earnings date of Applied Therapeutics Inc(APLT)?
The next earnings date of Applied Therapeutics Inc(APLT) is 2023-08-11 Est..
Does Applied Therapeutics Inc(APLT) pay dividends? If so, how much?
Applied Therapeutics Inc(APLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers